Bipolar Disorder in pediatric patients: A nationwide retrospective study from 2000 to 2015

André Campos1, Ana Rita Ferreira2, Manuel Gonçalves-Pinho3

  • 1Faculty of Medicine, University of Porto, Alameda Prof. Hêrnani Monteiro, 4200-319, Porto, Portugal.

Insights

Pediatric Bipolar Disorder (BD) hospitalizations in Portugal increased non-linearly from 2000-2015. The study highlights the need for better characterization to prevent acute admissions and readmissions in youth.

Area of Science:

  • Child and Adolescent Psychiatry
  • Public Health
  • Healthcare Management

Background:

  • Pediatric Bipolar Disorder (BD) is gaining attention globally.
  • No prior data existed on pediatric BD hospitalization rates in Portugal.
  • This study addresses the need for evidence on pediatric BD burden in Portugal.

Purpose of the Study:

  • To describe pediatric hospitalizations with a primary diagnosis of Bipolar Disorder in Portugal.
  • To characterize these hospitalizations between 2000 and 2015.
  • To provide data for understanding and potentially mitigating pediatric BD-related healthcare utilization.

Main Methods:

  • Retrospective observational study using a national administrative database.
  • Included pediatric inpatients (<18 years) with primary BD diagnosis (ICD-9-CM codes 296.x).
  • Analyzed demographics, comorbidities, length of stay, admission type, mortality, and charges.

Main Results:

  • Identified 348 hospitalizations (258 patients) with a rate of 1.18/100,000 youths.
  • Hospitalization rates showed a non-linear increase over the study period.
  • Patients were predominantly female (60.6%), median age 16, with 26% readmissions and significant associated costs (€1.20M total).

Conclusions:

  • Annual pediatric BD hospitalization rates exhibited a non-linear increase.
  • Findings contribute to understanding the pediatric BD burden in Portugal.
  • Further research is crucial to characterize trends and prevent high rates of acute hospitalizations and readmissions.
Abstract

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
168
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
371
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
32
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
425
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
27
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
23